Biohope partners with Duraent Lifesciences to introduce Immunobiogram® in India
We are proud to partner with Duraent Lifesciences to introduce Immunobiogram® in India, scaling access through a partner-led model
At Biohope, we built Immunobiogram®: a CE‑marked, patented pharmacodynamic IVD that maps a patient’s immune-cell response to immunosuppressants and delivers actionable drug‑sensitivity insights.
Kidney transplant immunosuppression is still managed largely by trial-and-error, despite the cost of rejection, infection and toxicity. By enabling clinicians to better understand how each patient’s immune system reacts to treatment, Immunobiogram® supports more precise therapeutic decisions and contributes to improving outcomes in kidney transplantation.
Every transplant journey deserves precision.
Every patient deserves personalized care
